EuroEyes International Eye Clinic Limited (HKG:1846)
2.880
+0.030 (1.05%)
At close: Mar 10, 2026
HKG:1846 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 914 | 1,287 | 1,736 | 1,829 | 2,693 | 2,878 | Upgrade
|
| Market Cap Growth | -7.77% | -25.85% | -5.10% | -32.07% | -6.41% | 4.30% | Upgrade
|
| Enterprise Value | 525 | 958 | 1,324 | 1,424 | 2,119 | 2,416 | Upgrade
|
| Last Close Price | 2.85 | 3.87 | 5.02 | 5.17 | 7.59 | 8.09 | Upgrade
|
| PE Ratio | 12.08 | 15.65 | 13.23 | 20.45 | 20.16 | 43.88 | Upgrade
|
| Forward PE | 8.64 | 8.67 | 9.68 | 7.60 | 19.32 | 34.78 | Upgrade
|
| PS Ratio | 1.26 | 1.80 | 2.43 | 3.00 | 4.26 | 6.07 | Upgrade
|
| PB Ratio | 0.70 | 1.14 | 1.49 | 1.75 | 2.59 | 2.91 | Upgrade
|
| P/TBV Ratio | 0.98 | 1.59 | 2.10 | 2.30 | 2.71 | 3.06 | Upgrade
|
| P/FCF Ratio | 6.95 | 10.96 | 16.87 | 11.98 | 11.75 | 71.73 | Upgrade
|
| P/OCF Ratio | 4.65 | 6.51 | 9.05 | 8.75 | 9.86 | 36.68 | Upgrade
|
| PEG Ratio | - | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | Upgrade
|
| EV/Sales Ratio | 0.72 | 1.34 | 1.85 | 2.33 | 3.35 | 5.10 | Upgrade
|
| EV/EBITDA Ratio | 2.45 | 6.80 | 6.16 | 8.16 | 9.63 | 17.89 | Upgrade
|
| EV/EBIT Ratio | 5.36 | 10.22 | 7.44 | 10.12 | 11.06 | 21.93 | Upgrade
|
| EV/FCF Ratio | 3.99 | 8.16 | 12.87 | 9.32 | 9.24 | 60.23 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.28 | 0.33 | 0.28 | 0.21 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 1.61 | 1.55 | 1.45 | 1.31 | 0.83 | 1.35 | Upgrade
|
| Debt / FCF Ratio | 2.63 | 2.72 | 3.73 | 1.90 | 0.97 | 5.97 | Upgrade
|
| Net Debt / Equity Ratio | -0.33 | -0.32 | -0.32 | -0.49 | -0.63 | -0.56 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.86 | -2.57 | -1.71 | -2.92 | -2.96 | -4.10 | Upgrade
|
| Net Debt / FCF Ratio | -3.23 | -3.08 | -3.58 | -3.34 | -2.84 | -13.81 | Upgrade
|
| Asset Turnover | 0.41 | 0.43 | 0.43 | 0.42 | 0.47 | 0.37 | Upgrade
|
| Inventory Turnover | 15.62 | 16.39 | 13.62 | 8.83 | 5.72 | 5.10 | Upgrade
|
| Quick Ratio | 3.69 | 4.52 | 4.47 | 4.93 | 6.38 | 6.59 | Upgrade
|
| Current Ratio | 3.81 | 4.69 | 4.62 | 5.12 | 6.72 | 7.10 | Upgrade
|
| Return on Equity (ROE) | 6.34% | 7.36% | 12.07% | 8.02% | 13.04% | 6.96% | Upgrade
|
| Return on Assets (ROA) | 3.48% | 3.49% | 6.75% | 6.05% | 8.92% | 5.41% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.71% | 8.01% | 18.71% | 19.79% | 31.45% | 20.18% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 6.50% | 11.20% | 10.20% | 15.60% | 9.30% | Upgrade
|
| Earnings Yield | 8.37% | 6.39% | 7.56% | 4.89% | 4.96% | 2.28% | Upgrade
|
| FCF Yield | 14.38% | 9.12% | 5.93% | 8.35% | 8.51% | 1.39% | Upgrade
|
| Dividend Yield | 2.15% | 1.67% | 1.99% | 1.21% | 1.31% | 0.37% | Upgrade
|
| Payout Ratio | 28.54% | 33.85% | 30.23% | 36.99% | 7.37% | 94.62% | Upgrade
|
| Buyback Yield / Dilution | 2.35% | 0.60% | 0.01% | -0.95% | 12.38% | -46.44% | Upgrade
|
| Total Shareholder Return | 4.37% | 2.26% | 2.00% | 0.26% | 13.68% | -46.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.